HSIC Henry Schein, Inc. - Common Stock
Henry Schein, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
Devamını oku
Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.
History
In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.
In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.
Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.
In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.
Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.
In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.
In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.
Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.
In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.
In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.
In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.
On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.
In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.
In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.
Operations
Dental
In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.
Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.
Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.
In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.
In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.
In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.
In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.
In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.
In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.
In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.
Henry Schein One
In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.
In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.
In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.
In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.
Medical
In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.
In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.
In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.
In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.
In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).
In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).
Former division
Animal health
Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.
Philanthropy
In 1998, Henry Schein's Back to School program was launched; this program provides underserved children with school supplies and has helped over 65,000 students since its foundation.
Since 1999, Henry Schein has held its annual ‘Holiday Cheer for Children’ program, which donates clothing, toys, and gift cards to over 20,000 children and their families throughout the holiday season.
In 2015, the Alpha Omega International Dental Society and Henry Schein Cares partnered to create the Alpha Omega-Henry Schein Cares Holocaust Survivors Oral Health Program, which offers pro bono oral care to Holocaust survivors. Since its inception, the program has provided treatment to over 1,600 individuals in the United States and Canada.
Since 2018, Henry Schein has supported the Special Olympics, in particular its Healthy Athletes program, through essential health care donations.
In April 2023, Henry Schein launched its Practice Green initiative, which seeks to encourage healthcare professionals to transition towards sustainable practices.
Henry Schein has also served as the exclusive product sponsor for the American Dental Association’s Give Kids A Smile Program. Henry Schein has contributed $20 million in oral health care products and more than 40,000 dental kits.
In April 2025, the Science Based Targets initiative (SBTi) approved Henry Schein's near-term and long-term science-based emissions reduction targets, verifying its net-zero science-based target by 2050.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
HSIC Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
HSIC Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
HSIC Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 7 28,0%
- Al 7 28,0%
- Tut 10 40,0%
- Sat 1 4,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
16 analist · 2026-08-19Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $1.27 | $1.26 | 0.01% |
| 31 Mart 2026 | $1.32 | $1.24 | 0.08% |
| 31 Aralık 2025 | $1.34 | $1.33 | 0.01% |
| 30 Eylül 2025 | $1.38 | $1.30 | 0.08% |
| 30 Haziran 2025 | $1.10 | $1.22 | -0.12% |
| 31 Mart 2025 | $1.15 | $1.13 | 0.02% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| HSIC | $8.81B | 23.3 | 4.0% | 3.0% | 12.0% | 31.1% |
| MCK | $242.30B | 22.5 | 12.4% | 1.2% | -224.3% | 3.6% |
| COR | $60.61B | 39.3 | 9.3% | 0.48% | 144.3% | 3.6% |
| CAH | — | 32.9 | 14.2% | 0.67% | -60.5% | 3.8% |
| AHCO | $1.35B | -19.2 | -0.49% | -2.2% | -4.6% | — |
| ACH | — | — | — | — | — | — |
| MEDS | — | — | — | — | — | — |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 17
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | $8.88B | $11.57B | $10.63B | |
| Cost of Revenue | $9.08B | $8.66B | $8.48B | $8.82B | $8.73B | $7.30B | $6.89B | $6.51B | $6.14B | $8.35B | $7.62B | |
| Gross Profit | $4.11B | $4.02B | $3.86B | $3.83B | $3.67B | $2.82B | $3.09B | $2.91B | $2.75B | $3.23B | $3.01B | |
| SG&A Expense | $3.08B | $3.03B | $2.96B | $2.77B | $2.63B | $2.09B | $2.36B | $2.22B | $2.07B | $2.41B | $2.24B | |
| Operating Expenses | · | · | · | · | · | · | · | $2.70B | $2.53B | $2.41B | · | |
| Operating Income | $653M | $621M | $615M | $747M | $852M | $535M | $718M | $601M | $670M | $772M | $734M | |
| Interest Expense | $150M | $131M | $87M | $35M | $27M | $41M | $51M | $76M | $51M | $32M | $26M | |
| Interest Income | $33M | $24M | $17M | $8M | $6M | $10M | $16M | $15M | $12M | $13M | $13M | |
| Other Non-op | $-3M | $-1M | $-3M | $1M | $0 | $-4M | $-3M | $-3M | $-1M | $3M | $-141.0K | |
| Pretax Income | $533M | $513M | $542M | $721M | $831M | $500M | $680M | $537M | $630M | $756M | $721M | |
| Income Tax | $126M | $128M | $120M | $170M | $198M | $95M | $160M | $107M | $309M | $218M | $211M | |
| Net Income | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | $406M | $507M | $479M | |
| EPS (Basic) | $3.29 | $3.07 | $3.18 | $3.95 | $4.51 | $2.83 | $4.70 | $3.51 | $2.59 | $3.14 | $2.89 | |
| EPS (Diluted) | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 | $2.82 | $4.65 | $3.49 | $2.57 | $3.10 | $2.85 | |
| Shares (Basic) | 120,813,977 | 126,788,997 | 130,618,990 | 136,064,221 | 140,090,889 | 142,504,193 | 147,817,000 | 152,656,000 | 156,787,000 | 161,641,000 | 165,687,000 | |
| Shares (Diluted) | 121,717,876 | 127,779,228 | 131,748,171 | 137,755,670 | 141,772,781 | 143,403,682 | 149,257,000 | 153,707,000 | 158,208,000 | 163,723,000 | 168,250,000 | |
| EBITDA | $964M | $918M | $863M | $959M | $1.06B | $721M | $903M | $961M | · | $941M | $893M |
Bilanço 26
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $156M | $122M | $171M | $117M | $118M | $421M | · | $57M | $158M | $62M | $72M | |
| Receivables | $1.65B | $1.48B | $1.86B | $1.44B | $1.45B | $1.42B | $1.25B | $1.17B | $1.52B | $1.25B | $1.23B | |
| Inventory | $2.00B | $1.81B | $1.81B | $1.96B | $1.86B | $1.51B | $1.43B | $1.42B | $1.93B | $1.67B | $1.51B | |
| Prepaid Expense | $655M | $569M | $639M | $466M | $413M | $433M | $445M | $451M | $455M | $361M | $361M | |
| Current Assets | $4.46B | $3.98B | $4.49B | $3.99B | $3.84B | $3.79B | $3.23B | $4.18B | $4.09B | $3.34B | $3.23B | |
| PP&E (Net) | · | · | · | · | $366M | $342M | $330M | $314M | $375M | $334M | $318M | |
| PP&E (Gross) | $1.38B | $1.20B | $1.17B | $956M | $916M | $868M | $799M | $905M | $990M | $865M | $797M | |
| Accum. Depreciation | $759M | $670M | $672M | $573M | $550M | $526M | $469M | $591M | $615M | $531M | $478M | |
| Goodwill | $4.21B | $3.89B | $3.88B | $2.89B | $2.85B | $2.50B | $2.46B | $2.08B | $1.55B | $2.02B | $1.91B | |
| Intangibles | $1.02B | $1.02B | $916M | $587M | $668M | $479M | $573M | $376M | $670M | $621M | $593M | |
| Total Assets | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.81B | $6.53B | |
| Accounts Payable | $1.15B | $962M | $1.02B | $1.00B | $1.05B | $1.01B | $880M | $786M | $1.15B | $1.01B | $1.01B | |
| Short-term Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | $951M | · | · | · | |
| Current Liabilities | $3.23B | $2.80B | $2.68B | $2.22B | $2.31B | $2.28B | $2.04B | $3.22B | $2.83B | $2.32B | $2.15B | |
| Capital Leases | $251M | $259M | $310M | $275M | $268M | $239M | $176M | $0 | · | · | · | |
| Deferred Tax | $146M | $102M | $54M | $36M | $42M | $30M | $65M | $27M | $50M | $52M | $253M | |
| Other Non-current Liabilities | $486M | $387M | $436M | $361M | $377M | $393M | $331M | $358M | $420M | $264M | $212M | |
| Total Liabilities | $6.42B | $5.38B | $5.42B | $3.94B | $3.81B | $3.46B | $3.23B | $4.65B | $4.21B | $3.35B | $3.08B | |
| Long-term Debt | · | · | · | $1.05B | $822M | · | · | · | · | · | · | |
| Total Debt | $764M | $650M | $264M | $103M | $51M | $73M | $24M | · | · | · | · | |
| Paid-in Capital | $177M | $0 | $0 | $0 | $0 | $0 | $48M | $0 | · | · | · | |
| Retained Earnings | $3.29B | $3.77B | $3.86B | $3.68B | $3.60B | $3.45B | $3.12B | $3.21B | $2.94B | $2.98B | $2.90B | |
| AOCI | $-226M | $-379M | $-206M | $-233M | $-171M | $-108M | $-167M | $-249M | $-130M | $-317M | $-220M | |
| Stockholders' Equity | $3.25B | $3.39B | $3.65B | $3.45B | $3.42B | $3.35B | $3.00B | $2.96B | $2.81B | $2.79B | $2.88B | |
| Liabilities + Equity | $11.21B | $10.22B | $10.57B | $8.61B | $8.48B | $7.77B | $7.15B | $8.50B | $7.86B | $6.76B | $6.50B | |
| Shares Outstanding | 115,771,149 | 124,155,884 | 129,247,765 | 131,792,817 | 137,145,558 | 142,462,571 | 143,353,459 | 151,401,668 | 153,690,146 | 158,805,010 | 164,830,640 |
Nakit Akışı 19
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $311M | $297M | $248M | $212M | $210M | $186M | $185M | $144M | $134M | $170M | $159M | |
| Stock-based Comp | $39M | $39M | $39M | $54M | $78M | $9M | $45M | $33M | $37M | $58M | $45M | |
| Deferred Tax | $5M | $-61M | $-20M | $-73M | $-11M | $-53M | $-4M | $-25M | $1M | $-37M | $-6M | |
| Amort. of Intangibles | $180M | $185M | $152M | $126M | $124M | $106M | $108M | $75M | $70M | $98M | $93M | |
| Restructuring | $105M | $110M | $80M | $128M | $8M | · | · | $54M | $0 | $46M | $35M | |
| Other Non-cash | $-41M | $183M | $-183M | $-129M | $-199M | $54M | $-266M | $-54M | · | $-82M | $-90M | |
| Operating Cash Flow | $712M | $848M | $500M | $602M | $710M | $599M | $654M | $685M | $546M | $643M | $616M | |
| CapEx | $139M | $148M | $147M | $96M | $79M | $49M | $76M | $71M | $62M | $70M | $72M | |
| Investing Cash Flow | $-400M | $-430M | $-1.14B | $-276M | $-677M | $-115M | $-424M | $-193M | $-342M | $-316M | $-260M | |
| Debt Issued | $489M | $120M | $1.37B | $270M | $305M | $501M | $741.0K | $115M | $200M | $261M | $135M | |
| Net Debt Issued | $445M | $-198M | $900M | $211M | $183M | $-110M | $-260M | $87M | · | $245M | $-66M | |
| Stock Issued | $250M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Repurchased | $850M | $385M | $250M | $485M | $401M | $74M | $525M | $200M | $450M | $550M | $300M | |
| Net Stock Activity | $-600M | $-385M | $-250M | $-485M | $-401M | $-74M | $-525M | $-200M | · | $-550M | $-300M | |
| Financing Cash Flow | $-188M | $-510M | $701M | $-315M | $-333M | $-187M | $-216M | $-604M | $-113M | $-327M | $-348M | |
| Net Change in Cash | $34M | $-49M | $54M | $-1M | $-303M | $315M | $26M | $-94M | $225M | $-10M | $-17M | |
| Taxes Paid | $128M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $573M | $700M | $353M | $506M | $631M | $550M | $578M | $594M | · | $545M | $515M | |
| Levered FCF | $458M | $602M | $285M | $472M | $610M | $517M | $539M | $533M | · | $523M | $497M |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% | 27.8% | 30.9% | 27.2% | · | 28.0% | 28.3% | |
| Operating Margin | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% | 5.3% | 7.2% | 5.7% | · | 6.7% | 6.9% | |
| Net Margin | 3.0% | 3.1% | 3.4% | 4.2% | 5.1% | 4.0% | 7.0% | 4.1% | · | 4.4% | 4.5% | |
| Pretax Margin | 4.0% | 4.0% | 4.4% | 5.7% | 6.7% | 4.9% | 6.8% | 5.3% | · | 6.5% | 6.8% | |
| EBITDA Margin | 7.3% | 7.2% | 7.0% | 7.6% | 8.6% | 7.1% | 9.0% | 7.3% | · | 8.1% | 8.4% | |
| ROA | 3.7% | 3.8% | 4.3% | 6.3% | 7.8% | 5.4% | 8.9% | 6.6% | · | 7.6% | 7.6% | |
| ROE | 12.0% | 11.1% | 11.7% | 15.7% | 18.6% | 12.7% | 23.3% | 18.6% | · | 17.8% | 16.8% | |
| ROIC | 12.4% | 11.5% | 12.2% | 16.1% | 18.7% | 12.7% | 18.2% | 19.7% | · | 19.7% | 18.0% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 | 1.7 | 1.6 | 1.3 | · | 1.4 | 1.5 | |
| Quick Ratio | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 | 0.6 | 0.6 | 0.5 | · | 0.6 | 0.6 | |
| Debt / Equity | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | · | · | · | · | |
| Interest Coverage | 4.4 | 4.7 | 7.1 | 17.0 | 30.9 | 12.9 | 14.1 | 9.6 | · | 24.2 | 28.2 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.2 | 1.2 | 1.3 | 1.5 | 1.5 | 1.4 | 1.3 | 1.6 | · | 1.7 | 1.7 | |
| Inventory Turnover | 4.8 | 4.8 | 4.5 | 4.6 | 5.2 | 5.0 | 4.8 | 4.9 | · | 5.3 | 5.4 | |
| Receivables Turnover | 8.4 | 7.6 | 7.5 | 8.7 | 8.6 | 7.6 | 8.3 | 8.4 | · | 9.3 | 9.0 |
Büyüme Oranları 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 4.0% | 2.7% | -2.4% | 2.0% | 22.6% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.4% | 0.73% | 6.8% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 5.4% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 7.2% | -3.5% | -19.2% | -12.1% | 57.8% | · | · | · | · | · | · | |
| EPS CAGR 3Y | -5.8% | -11.8% | 3.9% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 3.0% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 2.1% | -6.2% | -22.7% | -14.7% | 56.2% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -9.6% | -14.8% | 0.98% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.30% | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B | $10.12B | $9.99B | $9.42B | · | $11.57B | $10.63B | |
| Net Income TTM | $398M | $390M | $416M | $538M | $631M | $404M | $695M | $536M | · | $507M | $479M | |
| Market Cap | $8.81B | $8.74B | $9.79B | $10.53B | $10.28B | $9.38B | $9.54B | $9.25B | · | $4.72B | $5.08B | |
| Enterprise Value | $9.42B | $9.27B | $9.88B | $10.51B | $10.21B | · | · | · | · | · | · | |
| P/E | 23.3 | 23.1 | 24.0 | 20.4 | 16.8 | 23.3 | 14.3 | 17.5 | · | 19.2 | 21.6 | |
| P/S | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | 0.9 | 1.0 | 1.0 | · | 0.4 | 0.5 | |
| P/B | 2.7 | 2.6 | 2.7 | 3.1 | 3.0 | 2.8 | 3.2 | 3.1 | · | 1.7 | 1.8 | |
| P / Tangible Book | · | · | · | · | · | 25.7 | · | · | · | · | · | |
| P / Cash Flow | 12.4 | 10.3 | 19.6 | 17.5 | 14.5 | 15.7 | 14.6 | 13.5 | · | 7.7 | 8.7 | |
| P / FCF | 15.4 | 12.5 | 27.7 | 20.8 | 16.3 | 17.0 | 16.5 | 15.6 | · | 8.7 | 9.9 | |
| EV / EBITDA | 9.8 | 10.1 | 11.4 | 11.0 | 9.6 | · | · | · | · | · | · | |
| EV / FCF | 16.4 | 13.2 | 28.0 | 20.8 | 16.2 | · | · | · | · | · | · | |
| EV / Revenue | 0.7 | 0.7 | 0.8 | 0.8 | 0.8 | · | · | · | · | · | · | |
| Earnings Yield | 4.3% | 4.3% | 4.2% | 4.9% | 5.9% | 4.3% | 7.0% | 5.7% | · | 5.2% | 4.6% |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B | $3.17B | $3.14B | $3.17B | $3.02B | $3.16B | $3.06B | $3.37B | $3.07B | |
| Cost of Revenue | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B | $2.18B | $2.12B | $2.16B | $2.09B | $2.17B | $2.09B | $2.37B | $2.15B | |
| Gross Profit | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993M | $993M | $1.02B | $1.01B | $924M | $995M | $966M | $999M | $914M | |
| SG&A Expense | $831M | $809M | $808M | $760M | $778M | $738M | $738M | $724M | $781M | $791M | $807M | $725M | $717M | $761M | $648M | |
| Operating Income | $171M | $182M | $163M | $164M | $151M | $175M | $155M | $157M | $159M | $150M | $39M | $200M | $175M | $72M | $211M | |
| Interest Expense | $43M | $39M | $39M | $38M | $38M | $35M | $35M | $34M | $32M | $30M | $29M | $25M | $14M | $12M | $8M | |
| Interest Income | $8M | $7M | $9M | $9M | $9M | $6M | $6M | $7M | $6M | $5M | $5M | $6M | $3M | $3M | $1M | |
| Other Non-op | $1M | $0 | $0 | $-1M | $-1M | $-1M | $0 | $-2M | $-1M | $2M | $-1M | $-2M | $-1M | $0 | $1M | |
| Pretax Income | $137M | $150M | $133M | $134M | $121M | $145M | $126M | $128M | $132M | $127M | $14M | $179M | $163M | $63M | $205M | |
| Income Tax | $34M | $38M | $32M | $28M | $31M | $35M | $31M | $32M | $33M | $32M | $1M | $39M | $39M | $15M | $46M | |
| Net Income | $94M | $107M | $101M | $101M | $86M | $110M | $94M | $99M | $104M | $93M | $18M | $137M | $121M | $47M | $150M | |
| EPS (Basic) | $0.83 | $0.93 | $0.85 | $0.84 | $0.71 | $0.89 | $0.75 | $0.79 | $0.81 | $0.72 | $0.14 | $1.06 | $0.92 | $0.37 | $1.10 | |
| EPS (Diluted) | $0.82 | $0.92 | $0.85 | $0.84 | $0.70 | $0.88 | $0.75 | $0.78 | $0.80 | $0.72 | $0.14 | $1.05 | $0.91 | $0.36 | $1.09 | |
| Shares (Basic) | 113,451,329 | 114,939,640 | -245,089,515 | 120,199,552 | 121,927,867 | 123,776,073 | -255,840,759 | 126,124,715 | 127,784,380 | 128,720,661 | -269,727 | 130,388,353 | 131,365,789 | -274,191,526 | 135,608,678 | |
| Shares (Diluted) | 114,390,366 | 116,061,244 | -246,803,540 | 121,036,247 | 122,636,948 | 124,848,221 | -257,691,792 | 127,054,934 | 128,646,506 | 129,769,580 | -401,001 | 131,442,135 | 133,039,886 | -277,434,915 | 137,084,049 | |
| EBITDA | $255M | $263M | · | $244M | $151M | $248M | · | $157M | $159M | $223M | · | $200M | $227M | · | $211M |
Bilanço 24
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $157M | $138M | $156M | $136M | $145M | $127M | $122M | $126M | $138M | $159M | · | $166M | $126M | · | · | |
| Receivables | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B | $1.66B | $1.56B | $1.64B | $1.86B | $1.57B | $1.47B | $1.44B | $1.51B | |
| Inventory | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B | $1.75B | $1.66B | $1.69B | · | $1.83B | $1.92B | · | $1.82B | |
| Prepaid Expense | $621M | $625M | $655M | $604M | $545M | $490M | $569M | $607M | $587M | $589M | · | $541M | $438M | · | $509M | |
| Current Assets | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B | $4.15B | $3.94B | $4.08B | · | $4.11B | $3.95B | · | $3.96B | |
| PP&E (Gross) | · | · | $1.38B | · | · | · | $1.20B | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $759M | · | · | · | $670M | · | · | · | · | · | · | · | · | |
| Goodwill | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B | $3.99B | $3.90B | $3.83B | $3.88B | $3.60B | $2.92B | $2.89B | $2.87B | |
| Intangibles | $965M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B | $1.10B | $1.08B | $915M | · | $834M | $548M | · | $635M | |
| Total Assets | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Accounts Payable | $1.14B | $1.04B | $1.15B | $1.03B | $918M | $908M | $962M | $1.03B | $867M | $879M | · | $953M | $855M | · | $957M | |
| Short-term Debt | $1.02B | $1.05B | $764M | $913M | $901M | $867M | $650M | $638M | $505M | $264M | · | $12M | $236M | · | $107M | |
| Current Liabilities | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B | $2.93B | $2.55B | $2.33B | · | $2.09B | $2.17B | · | $2.15B | |
| Capital Leases | $275M | $263M | $251M | $264M | $259M | $256M | $259M | $262M | $261M | $266M | · | $314M | $274M | · | $271M | |
| Deferred Tax | $153M | $158M | $146M | $144M | $147M | $135M | $102M | $123M | $115M | $77M | · | $91M | $40M | · | $37M | |
| Other Non-current Liabilities | $442M | $437M | $486M | $487M | $504M | $485M | $387M | $414M | $431M | $423M | · | $396M | $368M | · | $338M | |
| Total Liabilities | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B | $5.63B | $5.25B | $5.11B | · | $4.71B | $3.88B | · | $3.73B | |
| Total Debt | $1.02B | $1.05B | · | $913M | $901M | $867M | · | $638M | $505M | $264M | · | $12M | · | · | $107M | |
| Paid-in Capital | $140M | $167M | $177M | $207M | $186M | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | $0 | |
| Retained Earnings | $3.20B | $3.29B | $3.29B | $3.38B | $3.48B | $3.63B | $3.77B | $3.77B | $3.80B | $3.84B | · | $3.90B | $3.68B | · | $3.92B | |
| AOCI | $-184M | $-189M | $-226M | $-222M | $-227M | $-317M | $-379M | $-264M | $-292M | $-239M | $-206M | $-247M | $-213M | $-233M | $-312M | |
| Stockholders' Equity | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B | $3.50B | $3.51B | $3.60B | · | $3.65B | $3.47B | · | $3.61B | |
| Liabilities + Equity | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B | $10.61B | $10.25B | $10.14B | · | $9.81B | $8.57B | · | $8.53B | |
| Shares Outstanding | 111,916,222 | 114,424,682 | 115,771,149 | 118,567,917 | 121,895,045 | 122,243,683 | 124,155,884 | 125,154,194 | 127,080,545 | 128,480,909 | 129,247,765 | 129,935,883 | 131,196,783 | 131,792,817 | 135,258,887 |
Nakit Akışı 17
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $84M | $81M | $82M | $80M | $76M | $73M | $76M | $74M | $74M | $73M | $68M | $69M | $52M | $52M | $52M | |
| Stock-based Comp | $13M | $3M | $10M | $13M | $11M | $5M | $9M | $10M | $12M | $8M | $1M | $14M | $10M | $10M | $17M | |
| Deferred Tax | $-10M | $2M | $5M | $7M | $0 | $-7M | $-20M | $-22M | $-21M | $2M | $-16M | $-1M | $2M | $-53M | $-5M | |
| Restructuring | $29M | $12M | $23M | $34M | $23M | $25M | $37M | $48M | $15M | $10M | · | $11M | $30M | · | $9M | |
| Other Non-cash | · | $-290M | · | · | · | $-144M | · | · | · | $21M | · | · | $-158M | · | · | |
| Operating Cash Flow | $242M | $-97M | $381M | $174M | $120M | $37M | $204M | $151M | $296M | $197M | $-32M | $231M | $27M | $254M | $98M | |
| CapEx | $30M | $25M | $43M | $33M | $32M | $31M | $36M | $34M | $37M | $41M | $39M | $40M | $31M | $29M | $24M | |
| Investing Cash Flow | $-65M | $-63M | $-147M | $-56M | $-98M | $-99M | $-58M | $-91M | $-209M | $-72M | $-327M | $-468M | $-39M | $-65M | $-152M | |
| Debt Issued | $87M | $57M | $175M | $70M | $94M | $150M | $0 | $30M | $0 | $90M | $210M | $750M | $31M | $105M | $165M | |
| Net Debt Issued | · | $18M | · | · | · | $135M | · | · | · | $30M | · | · | $30M | · | · | |
| Stock Issued | · | · | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Stock Repurchased | $200M | $125M | $200M | $203M | $286M | $161M | $75M | $135M | $100M | $75M | $50M | $50M | $100M | $285M | $90M | |
| Net Stock Activity | · | $-125M | · | · | · | $-161M | · | · | · | $-75M | · | · | $-100M | · | · | |
| Financing Cash Flow | $-168M | $120M | $-206M | $-127M | $56M | $89M | $-204M | $-41M | $-114M | $-151M | $394M | $248M | $21M | $-194M | $74M | |
| Net Change in Cash | $19M | $-18M | $20M | $-9M | $18M | $5M | $-4M | $-12M | $-21M | $-12M | $5M | $29M | $9M | $-6M | $15M | |
| Free Cash Flow | · | $-122M | · | · | · | $6M | · | · | · | $156M | · | · | $-4M | · | · | |
| Levered FCF | · | $-151M | · | · | · | $-21M | · | · | · | $134M | · | · | $-15M | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.8% | 31.8% | · | 30.7% | 31.4% | 31.6% | · | 31.3% | 32.5% | 31.9% | · | 31.5% | 31.6% | · | 29.8% | |
| Operating Margin | 5.0% | 5.4% | · | 4.9% | 4.7% | 5.5% | · | 5.0% | 5.1% | 4.7% | · | 6.3% | 5.7% | · | 6.9% | |
| Net Margin | 2.7% | 3.2% | · | 3.0% | 2.6% | 3.5% | · | 3.1% | 3.3% | 2.9% | · | 4.3% | 4.0% | · | 4.9% | |
| Pretax Margin | 4.0% | 4.5% | · | 4.0% | 3.7% | 4.6% | · | 4.0% | 4.2% | 4.0% | · | 5.7% | 5.3% | · | 6.7% | |
| EBITDA Margin | 7.4% | 7.8% | · | 7.3% | 4.7% | 7.8% | · | 5.0% | 5.1% | 7.0% | · | 6.3% | 7.4% | · | 6.9% | |
| ROA | 0.84% | 0.98% | · | 0.93% | 0.81% | 1.1% | · | 0.97% | 1.1% | 0.99% | · | 1.5% | · | · | 1.8% | |
| ROE | 2.9% | 3.2% | · | 2.9% | 2.5% | 3.2% | · | 2.8% | 2.9% | 2.6% | · | 3.8% | · | · | 4.2% | |
| ROIC | 3.1% | 3.1% | · | 3.0% | 2.6% | 3.2% | · | 2.8% | 3.0% | 2.9% | · | 4.3% | · | · | 4.4% |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.4 | 1.5 | 1.7 | · | 2.0 | · | · | 1.8 | |
| Quick Ratio | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.8 | · | 0.8 | · | · | 0.7 | |
| Debt / Equity | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.2 | 0.1 | 0.1 | · | 0.0 | · | · | 0.0 | |
| Interest Coverage | 4.0 | 4.7 | · | 4.3 | 4.0 | 5.0 | · | 4.6 | 5.0 | 5.0 | · | 8.0 | 12.5 | · | 19.2 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | 0.4 | |
| Inventory Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | · | · | 1.2 | |
| Receivables Turnover | 2.0 | 2.0 | · | 2.0 | 2.0 | 2.0 | · | 2.0 | 2.1 | 2.0 | · | 2.1 | · | · | 2.0 |
Değerleme (TTM) 14
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.40B | $13.12B | · | $12.92B | $12.72B | $12.65B | · | $12.64B | $12.57B | $12.49B | · | $12.39B | $12.34B | · | $12.45B | |
| Net Income TTM | $388M | $404M | · | $396M | $399M | $406M | · | $433M | $474M | $491M | · | $548M | $612M | · | $653M | |
| Market Cap | $9.51B | $8.25B | · | $7.83B | $8.93B | $8.39B | · | $9.16B | $8.15B | $9.70B | · | $9.65B | · | · | $9.11B | |
| Enterprise Value | $10.37B | $9.16B | · | $8.61B | $9.69B | $9.13B | · | $9.68B | $8.51B | $9.81B | · | $9.49B | · | · | · | |
| P/E | 25.9 | 21.6 | · | 20.6 | 23.2 | 21.6 | · | 21.9 | 17.7 | 20.2 | · | 18.1 | 18.3 | · | 14.3 | |
| P/S | 0.7 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | 0.7 | 0.6 | 0.8 | · | 0.8 | · | · | 0.7 | |
| P/B | 3.0 | 2.5 | · | 2.3 | 2.6 | 2.5 | · | 2.6 | 2.3 | 2.7 | · | 2.6 | · | · | 2.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 85.9 | |
| P / Cash Flow | · | -85.1 | · | · | · | 226.7 | · | · | · | 49.3 | · | · | · | · | · | |
| P / FCF | · | -67.6 | · | · | · | 1398.1 | · | · | · | 62.2 | · | · | · | · | · | |
| EV / EBITDA | 40.7 | 34.8 | · | 35.3 | 64.2 | 36.8 | · | 61.6 | 53.5 | 44.0 | · | 47.5 | · | · | · | |
| EV / FCF | · | -75.1 | · | · | · | 1521.4 | · | · | · | 62.9 | · | · | · | · | · | |
| EV / Revenue | 0.8 | 0.7 | · | 0.7 | 0.8 | 0.7 | · | 0.8 | 0.7 | 0.8 | · | 0.8 | · | · | · | |
| Earnings Yield | 3.9% | 4.6% | · | 4.8% | 4.3% | 4.6% | · | 4.6% | 5.7% | 5.0% | · | 5.5% | 5.5% | · | 7.0% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Gelir | $13.18B | $12.67B | $12.34B | $12.65B | $12.40B |
| Brüt Kâr Marjı % | 31.1% | 31.7% | 31.3% | 30.3% | 29.6% |
| Faaliyet Kâr Marjı % | 5.0% | 4.9% | 5.0% | 5.9% | 6.9% |
| Net Gelir | $398M | $390M | $416M | $538M | $631M |
| Seyreltilmiş Hisse Başı Kâr | $3.27 | $3.05 | $3.16 | $3.91 | $4.45 |
Bilanço
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 |
| Cari Oran | 1.4 | 1.4 | 1.7 | 1.8 | 1.7 |
| Cari Oran | 0.6 | 0.6 | 0.8 | 0.7 | 0.7 |
Nakit Akışı
| 2025-12-27 | 2024-12-28 | 2023-12-30 | 2022-12-31 | 2021-12-25 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $573M | $700M | $353M | $506M | $631M |
Son Haberler Bu şirketten bahseden son manşetler
İşlem Sinyalleri Giriş fiyatı ve risk/ödül oranı ile son alım/satım sinyalleri
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 603 dosya · $7.6B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 68 (-4 önceki Ç'ye göre) | 60 (+14 önceki Ç'ye göre) | 172 (-5 önceki Ç'ye göre) | 203 (+21 önceki Ç'ye göre) | +14.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| Kohlberg Kravis Roberts & Co. L.P. | $1.307.257.713 | 15.652.032 | 17,12% | Hisse senetleri |
| Artisan Partners Limited Partnership | $540.162.844 | 6.467.467 | 7,07% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $530.073.795 | 6.346.669 | 6,94% | Hisse senetleri |
| STATE STREET CORP | $359.576.652 | 4.305.276 | 4,71% | Hisse senetleri |
| FMR LLC | $349.717.366 | 4.187.229 | 4,58% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $345.225.076 | 4.133.442 | 4,52% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $288.743.396 | 3.457.175 | 3,78% | Hisse senetleri |
| Southpoint Capital Advisors LP | $275.616.000 | 3.300.000 | 3,61% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $256.689.867 | 3.073.394 | 3,36% | Hisse senetleri |
| CITADEL ADVISORS LLC | $243.970.272 | 2.921.100 | 3,20% | Hisse senetleri |
| Palestra Capital Management LLC | $204.347.632 | 2.446.691 | 2,68% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $200.544.294 | 2.405.837 | 2,63% | Hisse senetleri |
| FIDUCIARY MANAGEMENT INC /WI/ | $151.785.323 | 1.817.353 | 1,99% | Hisse senetleri |
| Burgundy Asset Management Ltd. | $151.049.204 | 2.170.871 | 1,98% | Hisse senetleri |
| LYRICAL ASSET MANAGEMENT LP | $122.553.156 | 1.467.351 | 1,60% | Hisse senetleri |
| Swedbank AB | $109.479.854 | 1.310.822 | 1,43% | Hisse senetleri |
| M.D. Sass, LLC | $107.485.396 | 1.286.942 | 1,41% | Hisse senetleri |
| SNYDER CAPITAL MANAGEMENT L P | $107.341.992 | 1.285.225 | 1,41% | Hisse senetleri |
| NORGES BANK | $103.383.729 | 1.237.832 | 1,35% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $86.592.951 | 1.036.793 | 1,13% | Hisse senetleri |
| NOMURA HOLDINGS INC | $77.065.658 | 922.721 | 1,01% | Hisse senetleri |
| PZENA INVESTMENT MANAGEMENT LLC | $71.888.420 | 860.733 | 0,94% | Hisse senetleri |
| Ananym Capital Management, LP | $57.978.164 | 694.183 | 0,76% | Hisse senetleri |
| Ulysses Management LLC | $55.570.700 | 665.358 | 0,73% | Hisse senetleri |
| STALEY CAPITAL ADVISERS INC | $55.252.489 | 661.548 | 0,72% | Hisse senetleri |
| DME Capital Management, LP | $52.173.274 | 624.680 | 0,68% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $45.489.502 | 544.654 | 0,60% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $35.970.895 | 430.686 | 0,47% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $35.392.853 | 423.765 | 0,46% | Hisse senetleri |
| Clarkston Capital Partners, LLC | $35.168.100 | 421.074 | 0,46% | Hisse senetleri |
| LONE PEAK GLOBAL INVESTORS LLC | $33.404.158 | 399.954 | 0,44% | Hisse senetleri |
| GAMCO INVESTORS, INC. ET AL | $30.537.668 | 365.633 | 0,40% | Hisse senetleri |
| PRIVATE MANAGEMENT GROUP INC | $27.285.483 | 326.694 | 0,36% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $25.194.142 | 301.654 | 0,33% | Hisse senetleri |
| BlackRock, Inc. | $24.670.305 | 295.382 | 0,32% | Hisse senetleri |
| GABELLI FUNDS LLC | $24.182.047 | 289.536 | 0,32% | Hisse senetleri |
| Zuckerman Investment Group, LLC | $24.062.613 | 288.106 | 0,32% | Hisse senetleri |
| JANE STREET GROUP, LLC | $22.976.352 | 275.100 | 0,30% | Alım opsiyonu |
| Petrus Trust Company, LTA | $22.550.400 | 270.000 | 0,30% | Hisse senetleri |
| P2 Capital Partners, LLC | $22.089.871 | 264.486 | 0,29% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $21.414.277 | 256.397 | 0,28% | Hisse senetleri |
| VAN LANSCHOT KEMPEN INVESTMENT MANAGEMENT N.V. | $21.151.189 | 253.247 | 0,28% | Hisse senetleri |
| RHUMBLINE ADVISERS | $21.008.017 | 251.534 | 0,28% | Hisse senetleri |
| UBS Group AG | $20.880.000 | 250.000 | 0,27% | Satım opsiyonu |
| LAZARD ASSET MANAGEMENT LLC | $20.493.720 | 245.375 | 0,27% | Hisse senetleri |
| Cresset Asset Management, LLC | $20.165.236 | 241.442 | 0,26% | Hisse senetleri |
| Balyasny Asset Management L.P. | $19.401.863 | 232.302 | 0,25% | Hisse senetleri |
| Quantinno Capital Management LP | $18.131.858 | 217.096 | 0,24% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $17.149.245 | 205.331 | 0,22% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $16.585.245 | 198.579 | 0,22% | Hisse senetleri |
| EVERETT HARRIS & CO /CA/ | $16.551.743 | 198.177 | 0,22% | Hisse senetleri |
| California Public Employees Retirement System | $16.351.212 | 195.776 | 0,21% | Hisse senetleri |
| Swiss National Bank | $16.344.864 | 195.700 | 0,21% | Hisse senetleri |
| Leith Wheeler Investment Counsel Ltd. | $15.975.960 | 191.283 | 0,21% | Hisse senetleri |
| WESTWOOD HOLDINGS GROUP INC | $15.708.859 | 188.085 | 0,21% | Hisse senetleri |
| Woodline Partners LP | $15.637.951 | 187.236 | 0,20% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $14.874.912 | 178.100 | 0,19% | Alım opsiyonu |
| Amundi | $14.369.366 | 172.047 | 0,19% | Hisse senetleri |
| Stephens Investment Management Group LLC | $14.100.765 | 168.831 | 0,18% | Hisse senetleri |
| NUANCE INVESTMENTS, LLC | $14.045.116 | 168.165 | 0,18% | Hisse senetleri |
| JANE STREET GROUP, LLC | $13.541.515 | 162.135 | 0,18% | Hisse senetleri |
| BARCLAYS PLC | $12.852.476 | 153.885 | 0,17% | Hisse senetleri |
| James J. Burns & Company, LLC | $12.843.455 | 153.777 | 0,17% | Hisse senetleri |
| Ulysses Management LLC | $12.528.000 | 150.000 | 0,16% | Alım opsiyonu |
| Marathon Asset Management Ltd | $11.609.195 | 139.002 | 0,15% | Hisse senetleri |
| CLARK ESTATES INC/NY | $11.275.200 | 135.000 | 0,15% | Hisse senetleri |
| PFM Health Sciences, LP | $11.227.009 | 134.423 | 0,15% | Hisse senetleri |
| Holocene Advisors, LP | $10.191.528 | 122.025 | 0,13% | Hisse senetleri |
| Mitsubishi UFJ Asset Management Co., Ltd. | $10.070.173 | 120.572 | 0,13% | Hisse senetleri |
| HEARTLAND ADVISORS INC | $10.022.400 | 120.000 | 0,13% | Hisse senetleri |
| BANK OF NOVA SCOTIA | $9.519.692 | 113.981 | 0,12% | Hisse senetleri |
| VICTORY CAPITAL MANAGEMENT INC | $9.502.822 | 113.779 | 0,12% | Hisse senetleri |
| HFR Wealth Management, LLC | $9.454.965 | 113.206 | 0,12% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $9.138.210 | 123.992 | 0,12% | Hisse senetleri |
| Illinois Municipal Retirement Fund | $8.914.173 | 106.731 | 0,12% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $8.898.137 | 106.539 | 0,12% | Hisse senetleri |
| Clearline Capital LP | $8.696.854 | 104.129 | 0,11% | Hisse senetleri |
| Stenger Family Office, LLC | $8.511.793 | 24.721 | 0,11% | Hisse senetleri |
| FIRST MANHATTAN CO. LLC. | $8.509.769 | 101.889 | 0,11% | Hisse senetleri |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $8.184.793 | 97.998 | 0,11% | Hisse senetleri |
| LAKEWOOD CAPITAL MANAGEMENT, LP | $8.101.440 | 97.000 | 0,11% | Hisse senetleri |
| Man Group plc | $7.975.325 | 95.490 | 0,10% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $7.705.472 | 92.259 | 0,10% | Hisse senetleri |
| BANYAN CAPITAL MANAGEMENT, INC. | $7.621.951 | 91.259 | 0,10% | Hisse senetleri |
| ENVESTNET ASSET MANAGEMENT INC | $7.521.178 | 90.052 | 0,10% | Hisse senetleri |
| NEUBERGER BERMAN GROUP LLC | $6.802.084 | 81.443 | 0,09% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $6.719.450 | 91.173 | 0,09% | Hisse senetleri |
| FRANKLIN RESOURCES INC | $6.613.615 | 79.186 | 0,09% | Hisse senetleri |
| Berger Financial Group, Inc | $6.535.023 | 78.245 | 0,09% | Hisse senetleri |
| WINTON GROUP Ltd | $6.439.392 | 77.100 | 0,08% | Hisse senetleri |
| RIVER GLOBAL INVESTORS LLP | $6.404.253 | 92.547 | 0,08% | Hisse senetleri |
| Brandywine Global Investment Management, LLC | $6.305.262 | 83.425 | 0,08% | Hisse senetleri |
| Foyston, Gordon & Payne Inc | $6.304.173 | 75.481 | 0,08% | Hisse senetleri |
| Allianz Asset Management GmbH | $6.210.714 | 74.362 | 0,08% | Hisse senetleri |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $6.145.736 | 73.584 | 0,08% | Hisse senetleri |
| AdvisorShares Investments LLC | $5.879.892 | 70.401 | 0,08% | Hisse senetleri |
| PNC Financial Services Group, Inc. | $5.687.294 | 68.095 | 0,07% | Hisse senetleri |
| Squarepoint Ops LLC | $5.369.083 | 64.285 | 0,07% | Hisse senetleri |
| Cinctive Capital Management LP | $5.110.088 | 61.184 | 0,07% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $4.965.598 | 59.454 | 0,07% | Hisse senetleri |
Şirket yöneticileri 51 içeriden öğrenenler · 23 yöneticiler · 21 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Andrea Albertini | CEO, Global Dist. & Tech. | 10 Aralık 2025 F | 65.900 | 0 | 0 | $0 |
| Bradford C Connett | CEO, NA Distribution Group | 19 Mart 2025 S | 62.688 | 0 | 0 | $0 |
| Thomas C Popeck | CEO, Henry Schein Products | 14 Mart 2025 D | 36.257 | 0 | 0 | $0 |
| David B Brous Jr | CEO, Strategic Business Group | 12 Haziran 2023 S | 68.690 | 0 | 0 | $0 |
| Karen Prange | EVP&CEO Gl.AH.Med.Den.Sur.Grp | 02 Mart 2018 A | 62.902 | 0 | 0 | $0 |
| Lonnie Shoff | CEO, Global Strat Port Grp | 15 Mart 2016 S | 31.000 | 0 | 0 | $0 |
| Ronald N. South | SVP & Chief Financial Officer | 14 Mart 2025 D | 81.374 | 0 | 0 | $0 |
| James P Breslawski | President | 14 Mart 2025 D | 200.227 | 0 | 0 | $0 |
| Bridget A Ross | President, Global Medical Grp | 06 Mart 2017 A | 9.654 | 0 | 0 | $0 |
| Michael Zack | President of Int'l Group | 07 Mart 2013 M | 48.716 | 0 | 0 | $0 |
| Michael S Ettinger | EVP & Chief Operating Officer | 19 Kasım 2025 G | 101.622 | 0 | 0 | $0 |
| Mark E Mlotek | EVP, Chief Strategic Officer | 16 Mart 2026 F | 98.372 | 0 | 2 | $-478.758 |
| Walter Siegel | Sr. VP & Chief Legal Officer | 14 Mart 2025 D | 43.191 | 0 | 0 | $0 |
| Lorelei Mcglynn | SVP, Chief Human Res. Officer | 06 Eylül 2024 S | 71.833 | 0 | 0 | $0 |
| Gerald A Benjamin | EVP, Chief Admin. Officer | 26 Mayıs 2022 S | 95.616 | 0 | 0 | $0 |
| David Mckinley | CCO&Pres. Corp. Com. Dev. Grp. | 30 Kasım 2018 S | 68.012 | 0 | 0 | $0 |
| Paul Rose | SVP, Global Supply Chain | 06 Eylül 2017 S | 17.841 | 0 | 0 | $0 |
| Robert Minowitz | Pres., Int'l Dental Group EMEA | 12 Mayıs 2017 S | 22.943 | 0 | 0 | $0 |
| Michael Racioppi | SVP Chief Merchandising Offic. | 20 Mart 2017 M | 23.088 | 0 | 0 | $0 |
| Peter M. Mccarthy | Pres., Global Animal Health | 13 Mart 2017 S | 14.277 | 0 | 0 | $0 |
| James A. Harding | SVP, Chief Technology Officer | 08 Mart 2017 S | 16.589 | 0 | 0 | $0 |
| Stanley Komaroff | Senior Advisor | 02 Mart 2016 F | 25.144 | 0 | 0 | $0 |
| Leonard A David | SVP, Chief Compliance Officer | 17 Mart 2015 S | 12.343 | 0 | 0 | $0 |
| William K Daniel | Yönetim kurulu üyesi | 12 Haziran 2026 A | 7.641 | 1 | 0 | $691.900 |
| Bradley T Sheares | Yönetim kurulu üyesi | 06 Mart 2026 A | 47.623 | 0 | 0 | $0 |
| Philip A Laskawy | Yönetim kurulu üyesi | 06 Mart 2026 A | 24.538 | 0 | 1 | $-228.544 |
| Reed Vaughn Tuckson | Yönetim kurulu üyesi | 11 Haziran 2025 F | 9.943 | 0 | 0 | $0 |
| Carol Raphael | Yönetim kurulu üyesi | 21 Mayıs 2025 F | 33.538 | 0 | 0 | $0 |
| Anne H. Margulies | Yönetim kurulu üyesi | 05 Mart 2025 F | 20.576 | 0 | 0 | $0 |
| Scott Philip Serota | Yönetim kurulu üyesi | 04 Mart 2025 A | 8.213 | 0 | 0 | $0 |
| Carole T Faig | Yönetim kurulu üyesi | 04 Mart 2025 A | 5.448 | 0 | 0 | $0 |
| Mohamad Ali | Yönetim kurulu üyesi | 04 Mart 2025 A | 12.498 | 0 | 0 | $0 |
| Robert J. Hombach | Yönetim kurulu üyesi | 04 Mart 2025 A | 2.844 | 0 | 0 | $0 |
| Steven Paladino | Yönetim kurulu üyesi | 04 Mart 2024 A | 138.272 | 0 | 0 | $0 |
| Dianne E Rekow | Yönetim kurulu üyesi | 16 Mart 2022 A | 18.526 | 0 | 0 | $0 |
| Barry J Alperin | Yönetim kurulu üyesi | 16 Mart 2022 A | 52.473 | 0 | 0 | $0 |
| Paul Brons | Yönetim kurulu üyesi | 03 Mart 2021 F | 16.854 | 0 | 0 | $0 |
| Shira Goodman | Yönetim kurulu üyesi | 03 Mart 2021 A | 5.689 | 0 | 0 | $0 |
| Lawrence S Bacow | Yönetim kurulu üyesi | 06 Mart 2018 F | 10.115 | 0 | 0 | $0 |
| Donald J Kabat | Yönetim kurulu üyesi | 06 Mart 2018 F | 10.874 | 0 | 0 | $0 |
| Louis W Sullivan | Yönetim kurulu üyesi | 31 Mart 2016 A | 14.096 | 0 | 0 | $0 |
| Norman S Matthews | Yönetim kurulu üyesi | 31 Mart 2016 A | 12.890 | 0 | 0 | $0 |
| Karyn Mashima | Yönetim kurulu üyesi | 10 Mart 2014 F | 19.269 | 0 | 0 | $0 |
| Irving Shafran | Yönetim kurulu üyesi | 20 Kasım 2003 S | 750.000 | 0 | 0 | $0 |
| HENRY SCHEIN INC | 10% sahip | 07 Şubat 2019 J | 0 | 0 | 0 | $0 |
| Stanley M Bergman | — | 26 Mayıs 2026 G | 253.279 | 0 | 5 | $-7.544.687 |
| Kurt P Kuehn | — | 10 Mart 2026 S | 15.420 | 0 | 1 | $-224.562 |
| Deborah Derby | — | 06 Mart 2026 A | 15.093 | 0 | 0 | $0 |
| Joseph L Herring | — | 06 Mart 2026 A | 30.325 | 0 | 0 | $0 |
| Margaret A Hamburg | — | 20 Mayıs 2009 M | 0 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| KKR Hawaii Holdings L.P., KKR Hawaii Holdings GP LLC, KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 başvurular | 10 Mart 2026 | 16,40% | Değişiklik | — | SEC |
| KKR Hawaii Aggregator L.P., KKR Hawaii Aggregator GP LLC, KKR North America Fund XIII SCSp, KKR Associates North America XIII SCSp, KKR North America XIII S.a r.l., KKR North America XIII Holdings Limited, MH Sub I, LLC, Indigo Intermediate Co II, LLC, IB Aggregator II L.P., KKR Indigo Aggregator III GP LLC, KKR Americas Fund XII (Indigo) L.P., KKR Associates Americas XII AIV L.P., KKR Americas XII AIV GP LLC, KKR Group Partnership L.P., KKR Group Holdings Corp., KKR Group Co. Inc., KKR & Co. Inc., KKR Management LLP, Henry R. Kravis, George R. Roberts ×4 başvurular | 08 Ağustos 2025 | 13,00% | Değişiklik | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 124 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| RSPH · Invesco Exchange-Traded Fund Trust | 1,69% | 150.301 SH | 08 Ağustos 2026 | Günlük |
| FLV · AMERICAN CENTURY ETF TRUST | 1,67% | 76.819 NS | 31 Mayıs 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 1,31% | 154.050 NS | 30 Nisan 2026 | N-PORT |
| GURU · Global X Funds | 1,05% | 8.187 NS | 30 Nisan 2026 | N-PORT |
| TAX · EA Series Trust | 0,98% | 3.244 NS | 29 Mayıs 2026 | N-PORT |
| RPV · Invesco Exchange-Traded Fund Trust | 0,64% | 123.268 SH | 08 Ağustos 2026 | Günlük |
| SMMV · iShares Trust | 0,60% | 19.668 SH | 08 Ağustos 2026 | Günlük |
| FBCV · FIDELITY COVINGTON TRUST | 0,35% | 7.509 NS | 30 Nisan 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,31% | 13.083 NS | 30 Nisan 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,31% | 17.947 NS | 30 Nisan 2026 | N-PORT |
| ANEW · ProShares Trust | 0,28% | 283 NS | 31 Mayıs 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,28% | 55.872 SH | 08 Ağustos 2026 | Günlük |
| ISCV · iShares Trust | 0,26% | 20.602 SH | 08 Ağustos 2026 | Günlük |
| DEUS · DBX ETF Trust | 0,22% | 7.905 NS | 29 Mayıs 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,22% | 4.614 NS | 31 Mayıs 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,21% | 2.354.606 SH | 08 Ağustos 2026 | Günlük |
| DFVE · DoubleLine ETF Trust | 0,21% | 765 NS | 31 Mart 2026 | N-PORT |
| SPXD · DBX ETF Trust | 0,20% | 181 NS | 31 Mayıs 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,20% | 16.567 NS | 30 Nisan 2026 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 0,18% | 245 NS | 31 Mayıs 2026 | N-PORT |
| ESML · iShares Trust | 0,18% | 58.273 SH | 08 Ağustos 2026 | Günlük |
| DFAS · Dimensional ETF Trust | 0,18% | 333.590 NS | 30 Nisan 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0,18% | 55.767 NS | 30 Nisan 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,17% | 1.416.056 SH | 08 Ağustos 2026 | Günlük |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 42.689 NS | 30 Nisan 2026 | N-PORT |
| SCHM · SCHWAB STRATEGIC TRUST | 0,14% | 270.326 NS | 31 Mayıs 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,14% | 4.118 NS | 30 Nisan 2026 | N-PORT |
| IYH · iShares Trust | 0,14% | 58.901 SH | 08 Ağustos 2026 | Günlük |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,14% | 24.631 NS | 30 Nisan 2026 | N-PORT |
| ISCB · iShares Trust | 0,13% | 4.208 SH | 08 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,13% | 48.980 NS | 30 Nisan 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,12% | 21.075 NS | 30 Nisan 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,12% | 293.098 SH | 08 Ağustos 2026 | Günlük |
| SMMD · iShares Trust | 0,12% | 49.577 SH | 08 Ağustos 2026 | Günlük |
| RXL · ProShares Trust | 0,11% | 1.043 NS | 31 Mayıs 2026 | N-PORT |
| IXJ · iShares Trust | 0,11% | 51.636 SH | 08 Ağustos 2026 | Günlük |
| CURE · Direxion Shares ETF Trust | 0,11% | 1.994 NS | 30 Nisan 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,10% | 2.230.411 SH | 08 Ağustos 2026 | Günlük |
| IEDI · iShares U.S. ETF Trust | 0,10% | 316 SH | 08 Ağustos 2026 | Günlük |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,10% | 9.299 SH | 08 Ağustos 2026 | Günlük |
| VFMF · VANGUARD WELLINGTON FUND | 0,09% | 7.550 SH | 08 Ağustos 2026 | Günlük |
| IWS · iShares Trust | 0,08% | 148.171 SH | 08 Ağustos 2026 | Günlük |
| DFAT · Dimensional ETF Trust | 0,08% | 146.387 NS | 30 Nisan 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 5.958 SH | 08 Ağustos 2026 | Günlük |
| TILT · FlexShares Trust | 0,08% | 20.790 NS | 30 Nisan 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 82.484 SH | 08 Ağustos 2026 | Günlük |
| VFVA · VANGUARD WELLINGTON FUND | 0,07% | 7.214 SH | 08 Ağustos 2026 | Günlük |
| JVAL · J.P. Morgan Exchange-Traded Fund Tr… | 0,07% | 6.605 NS | 30 Nisan 2026 | N-PORT |
| IWR · iShares Trust | 0,06% | 401.448 SH | 08 Ağustos 2026 | Günlük |
| JSTC · Tidal Trust I | 0,06% | 2.708 NS | 31 Mayıs 2026 | N-PORT |